Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludwig Knabl

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Impact of BNT162b first vaccination on the immune transcriptome of elderly patients infected with the B.1.351 SARS-CoV-2 variantLudwig Knabl, Hye Kyung Lee, Manuel Wieser, et al.
Communications Medicine|April 25, 2022
BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variantLudwig Knabl, Hye Kyung Lee, Manuel Wieser, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatientsHye Kyung Lee, Ludwig Knabl, Mary Walter, et al.
Rheumatology (Oxford, England)|May 9, 2022
Immune transcriptome and antibody response in adult-onset Still's disease with mild flare following administration of mRNA vaccine BNT162b2Ludwig Knabl, Hye Kyung Lee, Mary Walter, et al.
Viruses|December 28, 2021
Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 InfectionsSilke Huber, Mariam Massri, Marco Grasse, et al.
Iscience|October 21, 2022
Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatientsHye Kyung Lee, Ludwig Knabl, Mary Walter, et al.
Cell Reports|April 8, 2022
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include OmicronHye Kyung Lee, Ludwig Knabl, Juan I Moliva, et al.
European Journal of Medicinal Chemistry|October 17, 2020
Investigating the antibacterial activity of salen/salophene metal complexes: Induction of ferroptosis as part of the mode of actionDaniel Baecker, Özcan Sesli, Ludwig Knabl, et al.
Microbiology Spectrum|July 9, 2025
Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529Sissy Therese Sonnleitner, Samira Walder, Eva Hinterbichler, et al.
Research Square|September 30, 2020
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl communityHye Kyung Lee, Ludwig Knabl, Lisa Pipperger, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Impact of BNT162b first vaccination on the immune transcriptome of elderly patients infected with the B.1.351 SARS-CoV-2 variantLudwig Knabl, Hye Kyung Lee, Manuel Wieser, et al.
Communications Medicine|April 25, 2022
BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variantLudwig Knabl, Hye Kyung Lee, Manuel Wieser, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatientsHye Kyung Lee, Ludwig Knabl, Mary Walter, et al.
Rheumatology (Oxford, England)|May 9, 2022
Immune transcriptome and antibody response in adult-onset Still's disease with mild flare following administration of mRNA vaccine BNT162b2Ludwig Knabl, Hye Kyung Lee, Mary Walter, et al.
Viruses|December 28, 2021
Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 InfectionsSilke Huber, Mariam Massri, Marco Grasse, et al.
Iscience|October 21, 2022
Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatientsHye Kyung Lee, Ludwig Knabl, Mary Walter, et al.
Cell Reports|April 8, 2022
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include OmicronHye Kyung Lee, Ludwig Knabl, Juan I Moliva, et al.
European Journal of Medicinal Chemistry|October 17, 2020
Investigating the antibacterial activity of salen/salophene metal complexes: Induction of ferroptosis as part of the mode of actionDaniel Baecker, Özcan Sesli, Ludwig Knabl, et al.
Microbiology Spectrum|July 9, 2025
Decoding the transcriptome from bulk RNA of infection-naïve versus imprinted patients with SARS-CoV-2 Omicron B.1.1.529Sissy Therese Sonnleitner, Samira Walder, Eva Hinterbichler, et al.
Research Square|September 30, 2020
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl communityHye Kyung Lee, Ludwig Knabl, Lisa Pipperger, et al.
Pageof 6